LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 199

Search options

  1. Book: Lifestyle modification to control heart disease

    Shepard, Donald S.

    evidence and policy

    2010  

    Author's details ed. by Donald S. Shepard
    Keywords Coronary Disease / prevention & control ; Life Style ; Health Behavior ; Risk Reduction Behavior
    Language English
    Size XXIX, 232 S. : Ill., graph. Darst.
    Publisher Jones and Bartlett
    Publishing place Sudbury, Mass
    Publishing country United States
    Document type Book
    HBZ-ID HT016015755
    ISBN 978-0-7637-4947-7 ; 0-7637-4947-8
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Smart financial incentives to promote cardiovascular health.

    Shepard, Donald S

    Journal of cardiology & current research

    2020  Volume 13, Issue 1, Page(s) 11–13

    Language English
    Publishing date 2020-01-16
    Document type Journal Article
    ISSN 2373-4396
    ISSN (online) 2373-4396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cost-Effectiveness of Cardiac Rehabilitation in Older Adults With Coronary Heart Disease.

    Shepard, Donald S / Zakir, Shehreen / Gaalema, Diann E / Ades, Philip A

    Journal of cardiopulmonary rehabilitation and prevention

    2023  Volume 44, Issue 2, Page(s) 107–114

    Abstract: Purpose: While cardiac rehabilitation (CR) is recommended and effective following acute cardiac events, it remains underutilized, particularly in older adults. A study of 601 099 Medicare beneficiaries ≥65 yr hospitalized for coronary heart disease ... ...

    Abstract Purpose: While cardiac rehabilitation (CR) is recommended and effective following acute cardiac events, it remains underutilized, particularly in older adults. A study of 601 099 Medicare beneficiaries ≥65 yr hospitalized for coronary heart disease compared 5-yr mortality in users and nonusers of CR. Using instrumental variables (IV), CR improved mortality by 8.0% ( P < .001). A validation analysis based on 70 040 propensity-based (PB) matched pairs gave a similar gain (8.3%, P < .0001). The present cost-effectiveness analysis builds on these mortality results.
    Methods: Using the framework of the Second Panel on Cost-Effectiveness Analysis, we calculated the incremental cost-effectiveness ratio (ICER) gained due to CR. We accessed the costs from this cohort, inflated to 2022 prices, and assessed the relationship of quality-adjusted life years (QALY) to life years from a systematic review. We estimated the ICER of CR by modeling lifetime costs and QALY from national life tables using IV and PB.
    Results: Using IV, CR added 1.344 QALY (95% CI, 0.543-2.144) and $40 472 in costs over the remaining lifetimes of participants. The ICER was $30 188 (95% CI, $18 175-$74 484)/QALY over their lifetimes. Using the PB analysis, the corresponding lifetime values were 2.018 (95% CI, 1.001-3.035) QALY, $66 590, and an ICER of $32 996 (95% CI, $21 942-$66 494)/QALY.
    Conclusions: Cardiac rehabilitation was highly cost-effective using guidelines established by the World Health Organization and the US Department of Health and Human Services. The favorable clinical effectiveness and cost-effectiveness of CR, along with low use by Medicare beneficiaries, support the need to increase CR use.
    MeSH term(s) Humans ; Aged ; United States ; Cardiac Rehabilitation ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Medicare ; Coronary Disease ; Quality-Adjusted Life Years
    Language English
    Publishing date 2023-10-04
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 2272063-7
    ISSN 1932-751X ; 1932-7501
    ISSN (online) 1932-751X
    ISSN 1932-7501
    DOI 10.1097/HCR.0000000000000827
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Enrollment of dengue patients in a prospective cohort study in Umphang District, Thailand, during the COVID-19 pandemic: Implications for research and policy.

    Shepard, Donald S / Agarwal-Harding, Priya / Jiamton, Sukhum / Undurraga, Eduardo A / Kongsin, Sukhontha

    Health science reports

    2023  Volume 6, Issue 11, Page(s) e1657

    Abstract: Background and aims: Dengue is endemic in Thailand and imposes a high burden on the health system and society. We conducted a prospective cohort study in Umphang District, Tak Province, Thailand, to investigate the share of dengue cases with long ... ...

    Abstract Background and aims: Dengue is endemic in Thailand and imposes a high burden on the health system and society. We conducted a prospective cohort study in Umphang District, Tak Province, Thailand, to investigate the share of dengue cases with long symptoms and their duration. Here we present the results of the enrollment process during the COVID-19 pandemic with implications and challenges for research and policy.
    Methods: In a prospective cohort study conducted in Umphang District, Thailand, we examined the prevalence of persistent symptoms in dengue cases. Clinically diagnosed cases were offered free laboratory testing, We enrolled ambulatory dengue patients regardless of age who were confirmed through a highly sensitive laboratory strategy (positive NS1 and/or IgM), agreed to follow-up visits, and gave informed consent. We used multivariate logistic regressions to assess the probability of clinical dengue being laboratory confirmed. To determine the factors associated with study enrollment, we analyzed the relationship of patient characteristics and month of screening to the likelihood of participation. To identify underrepresented groups, we compared the enrolled cohort to external data sources.
    Results: The 150 clinical cases ranged from 1 to 85 years old. Most clinical cases (78%) were confirmed by a positive laboratory test, but only 19% of those confirmed enrolled in the cohort study. Women, who were half as likely to enroll as men, were underrepresented in the cohort.
    Conclusions: The Thai physicians' clinical diagnoses at this rural district hospital had good agreement with laboratory diagnoses. By identifying underrepresented groups and disparities, future studies can ensure the creation of statistically representative cohorts to maximize their scientific value. This involves recruiting and retaining underrepresented groups in health research, such as women in this study. Promising strategies for meaningful inclusion include multi-site enrollment, offering in-home or virtual services, and providing in-kind benefits like childcare for underrepresented groups.
    Language English
    Publishing date 2023-11-08
    Publishing country United States
    Document type Journal Article
    ISSN 2398-8835
    ISSN (online) 2398-8835
    DOI 10.1002/hsr2.1657
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cost-Effectiveness of Expanding Access to Primary Health Care in Rural Rwanda by Adding Laboratory-Equipped Health Posts: A Prospective, Controlled Study.

    Shepard, Donald S / Halasa-Rappel, Yara A / Zeng, Wu / Rowlands, Katharine R / Musange, Sabine F

    The American journal of tropical medicine and hygiene

    2023  Volume 108, Issue 5, Page(s) 1042–1051

    Abstract: To improve access to affordable primary health care and preventive services, in 2019 Rwanda's Ministry of Health inaugurated eight laboratory-equipped second-generation health posts (SGHPs) in the Bugesera District. Patient fees through Rwanda's ... ...

    Abstract To improve access to affordable primary health care and preventive services, in 2019 Rwanda's Ministry of Health inaugurated eight laboratory-equipped second-generation health posts (SGHPs) in the Bugesera District. Patient fees through Rwanda's insurance system (mutuelles) funded most operational costs through a public-private partnership. This prospective, controlled trial evaluated the posts' impact and cost-effectiveness. Our evaluation matched the rural cells containing these posts to eight control cells in Bugesera without formal health posts. We assessed costs using 2 years of financial data; accessed use statistics at SGHPs, health centers, and in the international literature; interviewed 1,952 randomly selected residents; conducted eight focus groups; and performed difference-in-differences regressions and survival analyses. Second-generation health posts increased primary care use by 1.83 outpatient visits per person per year (P < 0.0001). Of the 10 prevention indicators compared with trends, two improved significantly with SGHPs (two showed nonsignificant improvements), and one indicator experienced a significant deterioration. Second-generation health posts generated health improvements at a low cost and achieved a small, but favorable, 5% margin of revenues over financial costs. Second-generation health posts produced a very favorable incremental cost-effectiveness ratio of only $101 per disability-adjusted life year averted-only 13% of Rwanda's per-capita gross national income. In conclusion, SGHPs improved substantially the quantity of affordable outpatient care per person. However, net impacts on quality and completeness of care and prevention, although favorable, were small. For further improvements in access and quality of care, Rwanda's health authorities may wish to incentivize quality and strengthen coordination with other health system components.
    MeSH term(s) Humans ; Cost-Benefit Analysis ; Government Programs ; Primary Health Care ; Prospective Studies ; Rwanda
    Language English
    Publishing date 2023-03-20
    Publishing country United States
    Document type Controlled Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.22-0519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Corrigendum to "Decreasing smoking during pregnancy: Potential economic benefit of reducing sudden unexpected infant death" [Preventive Medicine 140 (2020) 106238].

    Higgins, Stephen T / Slade, Eric P / Shepard, Donald S

    Preventive medicine

    2021  Volume 154, Page(s) 106889

    Language English
    Publishing date 2021-11-21
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 184600-0
    ISSN 1096-0260 ; 0091-7435
    ISSN (online) 1096-0260
    ISSN 0091-7435
    DOI 10.1016/j.ypmed.2021.106889
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Analysis of hospital costs

    Shepard, Donald S. / Hodgkin, Dominic / Anthony, Yvonne E.

    a manual for managers

    2000  

    Author's details Donald S. Shepard ; Dominic Hodgkin ; Yvonne E. Anthony
    Keywords Krankenhaus ; Kostenanalyse ; Kostenmanagement
    Subject Kostenlenkung ; Unternehmen ; Klinik ; Klinikum ; Krankenanstalt ; Krankenhauswesen ; Spital ; Kostenauswertung
    Language English
    Size VIII, 92 S.
    Publisher World Health Organization
    Publishing place Geneva
    Publishing country Switzerland
    Document type Book
    HBZ-ID HT012745909
    ISBN 92-4-154528-3 ; 978-92-4-154528-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article: The potential impact of dengue vaccination with, and without, pre-vaccination screening

    Coudeville, Laurent / Baurin, Nicolas / Shepard, Donald S

    Vaccine. 2020 Feb. 05, v. 38, no. 6

    2020  

    Abstract: The World Health Organization defined a ‘screen and vaccinate’ strategy as its recommended policy for the licensed dengue vaccine (Dengvaxia, Sanofi Pasteur), so that only individuals with previous dengue infection are vaccinated. The objectives of the ... ...

    Abstract The World Health Organization defined a ‘screen and vaccinate’ strategy as its recommended policy for the licensed dengue vaccine (Dengvaxia, Sanofi Pasteur), so that only individuals with previous dengue infection are vaccinated. The objectives of the present study were to build upon a recently published analysis of the benefits and risks associated with dengue vaccination to evaluate the public health impact and cost-effectiveness of a screen and vaccinate strategy.The current analysis was based on a previously reported transmission model and added, for the screening part, three rapid diagnostic tests with identical specificity (99%) but alternative sensitivities (50-70-90%) in the detection of prior dengue infection. The impact of a screen-and-vaccinate strategy considered nine settings representing different levels of transmission intensity. Outcomes (dengue-related hospitalizations, severe dengue, and symptomatic dengue) were assessed according to the level of transmission setting. The cost-effectiveness of vaccination in 10 endemic countries was also assessed.Although associated, in most cases, with a lower population impact than a ‘no-screening’ approach, a screen and vaccinate strategy is more effective in reducing the number of hospitalized and severe cases prevented per vaccination performed and generates positive health benefits for individuals screened and subsequently vaccinated. As a result, this intervention is cost-effective in all countries considered except for very low transmission settings. The overall population impact of a screen and vaccinate approach is also likely to be improved by the use of several rounds of screening (up to 48% reduction in dengue hospitalization over 10 years with 5 rounds).WHO recommended option of a screen and vaccinate policy is likely to have a positive impact both at the individual and population level across a wide range of transmission settings and has the potential to be as, if not more, cost-effective than a no screening strategy.
    Keywords cost effectiveness ; dengue ; diagnostic techniques ; issues and policy ; models ; public health ; risk ; screening ; vaccination ; vaccines
    Language English
    Dates of publication 2020-0205
    Size p. 1363-1369.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2019.12.012
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Medical Respite for People Experiencing Homelessness: Financial Impacts with Alternative Levels of Medicaid Coverage.

    Shetler, Dan / Shepard, Donald S

    Journal of health care for the poor and underserved

    2018  Volume 29, Issue 2, Page(s) 801–813

    Abstract: Medical respite (MR) programs provide medical care, social services, and a safe place to recuperate for people experiencing homelessness after hospital discharge. We examined the financial impact of MR on hospitals and insurers in states with varying ... ...

    Abstract Medical respite (MR) programs provide medical care, social services, and a safe place to recuperate for people experiencing homelessness after hospital discharge. We examined the financial impact of MR on hospitals and insurers in states with varying Medicaid coverage. Urban case-study hospitals were selected from a state with Medicaid expansion under the Affordable Care Act (Connecticut) and without expansion (Florida). We calculated costs and savings from MR to hospitals and payers from the hospitals' financial data. These hospitals currently incur losses of 26% (Conn.) to 48% (Fla.) on inpatient care costs of patients experiencing homelessness. Medical respite would reduce these losses by reducing the index length of stay by two days, subsequent emergency department visits by 45%, and subsequent inpatient admissions by 35%, offsetting $1.81 in hospital costs for each dollar invested in MR. With appropriate sharing of costs between hospitals and payers, both would save money from MR.
    MeSH term(s) Connecticut ; Emergency Service, Hospital/statistics & numerical data ; Florida ; Homeless Persons ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Humans ; Insurance Coverage/statistics & numerical data ; Medicaid/economics ; Patient Discharge ; Patient Protection and Affordable Care Act ; Respite Care/economics ; United States
    Language English
    Publishing date 2018-05-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1142637-8
    ISSN 1548-6869 ; 1049-2089
    ISSN (online) 1548-6869
    ISSN 1049-2089
    DOI 10.1353/hpu.2018.0059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cost-Effectiveness of PBO versus Conventional Long-Lasting Insecticidal Bed Nets in Preventing Symptomatic Malaria in Nigeria: Results of a Pragmatic Randomized Trial.

    Shepard, Donald S / Odumah, John U / Awolola, Samson T

    The American journal of tropical medicine and hygiene

    2020  Volume 104, Issue 3, Page(s) 979–986

    Abstract: Insecticide treated nets (ITNs) have been the major tool in halving malaria's burden since 2000, but pyrethroid insecticide resistance threatens their ongoing effectiveness. In 2017, the WHO concluded that long-lasting ITNs (LLINs) with a synergist, ... ...

    Abstract Insecticide treated nets (ITNs) have been the major tool in halving malaria's burden since 2000, but pyrethroid insecticide resistance threatens their ongoing effectiveness. In 2017, the WHO concluded that long-lasting ITNs (LLINs) with a synergist, piperonyl butoxide (PBO), provided additional public health benefit over conventional (pyrethroid-only) LLINs alone in areas of moderate insecticide resistance and endorsed them as a new class of vector control products. We performed an economic appraisal of PBO nets compared with conventional LLINs in 2019 US$ from prevention and health systems perspectives (including treatment cost offsets). We used data from a pragmatic randomized 2012-2014 trial in Nigeria with epidemiological outcomes in an area with confirmed pyrethroid resistance. Each village had 50 months of epidemiologic data, analyzed by village by month, using negative binomial regression. Compared with LLINs, although adding $0.90 per net delivered, PBO nets reduced symptomatic malaria cases by 33.4% (95% CI 10.2-50.6%). From a prevention perspective, the incremental cost-effectiveness ratio was $11 (95% CI $8-$37) per disability-adjusted life year averted. From the health systems perspective, PBO nets were significantly cost-saving relative to conventional LLINs. The benefit-cost analysis found that the added economic benefits of PBO nets over LLINs were $201 (95% CI $61-$304) for every $1 in incremental costs. Growing pyrethroid resistance is likely to strengthen the economic value of PBO nets over LLINs. Beyond their contribution to reducing malaria, PBO nets deliver outstanding economic returns for a small additional cost above conventional LLINs in locations with insecticide resistance.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Anopheles/drug effects ; Child ; Child, Preschool ; Cost-Benefit Analysis ; Female ; Humans ; Infant ; Insecticide Resistance ; Insecticide-Treated Bednets ; Insecticides/pharmacology ; Malaria/epidemiology ; Malaria/prevention & control ; Male ; Middle Aged ; Nigeria/epidemiology ; Piperonyl Butoxide/economics ; Piperonyl Butoxide/pharmacology ; Pyrethrins/economics ; Pyrethrins/pharmacology ; Young Adult
    Chemical Substances Insecticides ; Pyrethrins ; Piperonyl Butoxide (LWK91TU9AH)
    Language English
    Publishing date 2020-12-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.20-0956
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top